Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination
Public ClinicalTrials.gov record NCT06007183. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long-term Follow-up Study to Evaluate Safety and Immunogenicity of a Chikungunya Virus Virus-like Particle Vaccine (CHIKV VLP) in Healthy Adults and Adolescents After Either a Single or Booster Vaccination Dosing Regimen
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this phase 3 multicenter, randomized, double-blind, placebo-controlled rollover study is to evaluate the safety and long-term immunogenicity of CHIKV VLP vaccine in adult and adolescent participants and to evaluate CHIKV VLP booster vaccine induced serum neutralizing antibody (SNA) response at 3 or 4 years post-initial CHIKV VLP vaccination.
Study identification
- NCT ID
- NCT06007183
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 715 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 29, 2023
- Primary completion
- Jan 31, 2028
- Completion
- Jan 31, 2028
- Last update posted
- Aug 6, 2026
2023 – 2028
United States locations
- U.S. sites
- 24
- U.S. states
- 17
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alliance for Multispecialty Research, LLC | Mobile | Alabama | 36608 | — |
| Alliance for Multispecialty Research, LLC | Tempe | Arizona | 85281 | — |
| Optimal Research, LLC | Melbourne | Florida | 32934 | — |
| Suncoast Research Associates, LLC | Miami | Florida | 33173 | — |
| Synexus Clinical Research US, Inc. | Chicago | Illinois | 60602 | — |
| Optimal Research, LLC | Peoria | Illinois | 61614 | — |
| Alliance for Multispecialty Research, LLC | Newton | Kansas | 67114 | — |
| Alliance for Multispecialty Research, LLC | Wichita | Kansas | 67207 | — |
| Alliance for Multispecialty Research, LLC | Lexington | Kentucky | 40509 | — |
| Alliance for Multispecialty Research, LLC | Kansas City | Missouri | 64114 | — |
| Wr-Crcn, Llc | Las Vegas | Nevada | 89106 | — |
| Alliance for Multispecialty Research, LLC | Las Vegas | Nevada | 89119 | — |
| Rochester Clinical Research, LLC | Rochester | New York | 14609 | — |
| M3 Wake Research Inc. | Raleigh | North Carolina | 27612 | — |
| Velocity Clinical Research, Cleveland | Cleveland | Ohio | 44122 | — |
| Lynn Institute of Norman | Norman | Oklahoma | 73072 | — |
| Velocity Clinical Research, Medford | Medford | Oregon | 97504 | — |
| Velocity Clinical Research, Providence | East Greenwich | Rhode Island | 02818 | — |
| Velocity Clinical Research, Austin | Cedar Park | Texas | 78613 | — |
| DM Clinical Research | Houston | Texas | 77081 | — |
| BFHC Research, LLC | San Antonio | Texas | 78249 | — |
| DM Clinical Research | Tomball | Texas | 77375 | — |
| Velocity Clinical Research, Salt Lake City | West Jordan | Utah | 84088 | — |
| Alliance for Multispecialty Research, LLC | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06007183, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 6, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06007183 live on ClinicalTrials.gov.